These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 28730407)

  • 21. Rivaroxaban attenuates thrombosis by targeting the NF-κB signaling pathway in a rat model of deep venous thrombus.
    Ma J; Li X; Wang Y; Yang Z; Luo J
    Int J Mol Med; 2017 Dec; 40(6):1869-1880. PubMed ID: 29039441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammation in venous thromboembolism: Cause or consequence?
    Saghazadeh A; Hafizi S; Rezaei N
    Int Immunopharmacol; 2015 Sep; 28(1):655-65. PubMed ID: 26253657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microparticles as biomarkers of venous thromboembolic events.
    Campello E; Spiezia L; Radu CM; Simioni P
    Biomark Med; 2016 Jul; 10(7):743-55. PubMed ID: 27338783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular DNA-A Danger Signal Triggering Immunothrombosis.
    Shi C; Yang L; Braun A; Anders HJ
    Front Immunol; 2020; 11():568513. PubMed ID: 33117353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunothrombosis and its underlying biological mechanisms.
    De Nardi AC; Coy-Canguçu A; Saito A; Florio MF; Marti G; Degasperi GR; Orsi FA
    Hematol Transfus Cell Ther; 2024; 46(1):49-57. PubMed ID: 37451977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of neutrophils in thrombosis.
    Kapoor S; Opneja A; Nayak L
    Thromb Res; 2018 Oct; 170():87-96. PubMed ID: 30138777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein, immunothrombosis and venous thromboembolism.
    Dix C; Zeller J; Stevens H; Eisenhardt SU; Shing KSCT; Nero TL; Morton CJ; Parker MW; Peter K; McFadyen JD
    Front Immunol; 2022; 13():1002652. PubMed ID: 36177015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
    Green D
    Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review.
    Niculae CM; Hristea A; Moroti R
    Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of procoagulants and anticoagulants in the development of venous thromboembolism.
    Bertina RM
    Thromb Res; 2009; 123 Suppl 4():S41-5. PubMed ID: 19303503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local hemostasis, immunothrombosis, and systemic disseminated intravascular coagulation in trauma and traumatic shock.
    Gando S; Otomo Y
    Crit Care; 2015 Feb; 19(1):72. PubMed ID: 25886801
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sepsis, thrombosis and organ dysfunction.
    Semeraro N; Ammollo CT; Semeraro F; Colucci M
    Thromb Res; 2012 Mar; 129(3):290-5. PubMed ID: 22061311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The emerging role of immunothrombosis in paediatric conditions.
    Franchi T; Eaton S; De Coppi P; Giuliani S
    Pediatr Res; 2019 Jul; 86(1):19-27. PubMed ID: 30808021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent Advances on the Molecular Mechanism and Clinical Trials of Venous Thromboembolism.
    Huang SL; Xin HY; Wang XY; Feng GG; Wu FQ; Feng ZP; Xing Z; Zhang XH; Xin HW; Luo WY
    J Inflamm Res; 2023; 16():6167-6178. PubMed ID: 38111686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thrombo-Inflammation in Cardiovascular Disease: An Expert Consensus Document from the Third Maastricht Consensus Conference on Thrombosis.
    d'Alessandro E; Becker C; Bergmeier W; Bode C; Bourne JH; Brown H; Buller HR; Ten Cate-Hoek AJ; Ten Cate V; van Cauteren YJM; Cheung YFH; Cleuren A; Coenen D; Crijns HJGM; de Simone I; Dolleman SC; Klein CE; Fernandez DI; Granneman L; van T Hof A; Henke P; Henskens YMC; Huang J; Jennings LK; Jooss N; Karel M; van den Kerkhof D; Klok FA; Kremers B; Lämmle B; Leader A; Lundstrom A; Mackman N; Mannucci PM; Maqsood Z; van der Meijden PEJ; van Moorsel M; Moran LA; Morser J; van Mourik M; Navarro S; Neagoe RAI; Olie RH; van Paridon P; Posma J; Provenzale I; Reitsma PH; Scaf B; Schurgers L; Seelig J; Siegbahn A; Siegerink B; Soehnlein O; Soriano EM; Sowa MA; Spronk HMH; Storey RF; Tantiwong C; Veninga A; Wang X; Watson SP; Weitz J; Zeerleder SS; Ten Cate H;
    Thromb Haemost; 2020 Apr; 120(4):538-564. PubMed ID: 32289858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities.
    Ryan TAJ; O'Neill LAJ
    Eur J Immunol; 2022 Jul; 52(7):1024-1034. PubMed ID: 35569038
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-modelling of venous thrombosis.
    Malgor RD; Labropoulos N
    Phlebology; 2013 Mar; 28 Suppl 1():25-8. PubMed ID: 23482530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for venous thromboembolism in children.
    Gerotziafas GT
    Int Angiol; 2004 Sep; 23(3):195-205. PubMed ID: 15765033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Role of Myeloid Cells in Thromboinflammatory Disease.
    Noone D; Preston RJS; Rehill AM
    Semin Thromb Hemost; 2024 Oct; 50(7):998-1011. PubMed ID: 38547918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.